 | • レポートコード：MRC2303M115 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査資料によると、世界の整形外科用装置市場規模が、予測期間中（2022年〜2027年）に年平均成長率4.9%で拡大すると予測されています。本書は、整形外科用装置の世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、用途別（整形外科用股関節装置、関節再建、整形外科用膝関節装置、整形外科用脊椎装置、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Aesculap Inc.、AGIS Network Inc.、Arthrex Inc.、ATEC Spine Inc.、B. Braun Melsungen AG、Boston Scientific Corporation、CTL Amedica、Globus Medical、Johnson & Johnson、Medtronic PLC、Ossur、Smith & Nephew PLC、Stryker Corporation、Zimmer Biometなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の整形外科用装置市場規模：用途別 - 整形外科用股関節装置における市場規模 - 関節再建における市場規模 - 整形外科用膝関節装置における市場規模 - 整形外科用脊椎装置における市場規模 - その他における市場規模 ・世界の整形外科用装置市場規模：地域別 - 北米の整形外科用装置市場規模 アメリカの整形外科用装置市場規模 カナダの整形外科用装置市場規模 メキシコの整形外科用装置市場規模 … - ヨーロッパの整形外科用装置市場規模 イギリスの整形外科用装置市場規模 フランスの整形外科用装置市場規模 ドイツの整形外科用装置市場規模 … - アジア太平洋の整形外科用装置市場規模 中国の整形外科用装置市場規模 インドの整形外科用装置市場規模 日本の整形外科用装置市場規模 … - 南米/中東の整形外科用装置市場規模 ブラジルの整形外科用装置市場規模 アルゼンチンの整形外科用装置市場規模 南アフリカの整形外科用装置市場規模 … - その他地域の整形外科用装置市場規模 ・競争状況 ・市場機会・将来の動向 |
The orthopedic devices market is expected to register a CAGR of about 4.9% over the forecast period, 2022-2027.
In 2020, due to lockdowns worldwide, private and public transport was stopped, which reduced road accidents and associated injuries. With that, in healthcare facilities, the treatment was shifted from orthopedic procedures to COVID-19 patients, which affected the market in the short term, particularly in specialty hospitals. Along with that, in a few regions, the orthopedic and small hospitals were shut down or their operations had been limited, and other hospitals were being converted to containment facilities and treatment wards for COVID-19 patients. According to the research published in August 2020, titled “Impact of COVID-19 on orthopedic surgery: Experience from Saudi Arabia,” orthopedic residency training has been adversely affected by the COVID-19 pandemic. The inevitable pausing of all elective surgeries has limited hands-on practice and exposure to a number of procedures. Although the orthopedic oncology service has continued, this is a limited area within the orthopedic training program, which includes at least nine sub-specialties. Trauma surgery has continued but at a much slower rate, most likely as a result of the nationwide lockdown, which had a short-term negative impact on the market.
According to the statistics of the Arthritis Foundation, in 2019, an estimated 30.8 million adults were found to be suffering from arthritis, and 14 million individuals in the United States were observed to be suffering from symptomatic knee osteoarthritis. By 2050, the number of adults in the United States with doctor-diagnosed osteoarthritis is projected to increase by 49% to 78.4 million or amounting to 25.9%. By 2040, the number of adults reporting activity limitations due to their arthritis is likely to increase by 52% to 34.6 million.
The number of people who went through joint replacement surgeries, such as total knee and hip replacement, has increased steadily and continues to rise due to an increase in the elderly population. The rise in musculoskeletal diagnoses and osteoporosis-related fractures is boosting the demand for orthopedic implants among the elderly population. New innovative products are one of the key factors driving the growth of the market. For instance, in November 2020, Aurora Spine Corporation launched the SOLOTM ALIF Stand-Alone Cage system used in spinal surgery. A stand-alone device, the SOLOTM is implanted through a single incision that promotes less trauma for the patient and saves valuable time for the surgical team. However, factors such as the stringent regulatory scenario, poor reimbursement scenario, and lack of skilled surgeons may hamper the growth of the market.
Orthopedic Devices Market Trends
The Joint Reconstruction Segment is Expected to Grow at a Healthy Rate Over the Forecast Period
With COVID-19 infections rising globally, there was a decline in both emergence and elective amputation surgeries, which may decline the demand for orthopedic devices and adversely impact the market growth. For instance, according to a study conducted by an international consortium in May 2020, more than 580,000 planned surgeries in India were canceled or delayed as a result of the COVID-19 pandemic. Such a decrease in surgery affected the growth of the market segment.
The joint reconstruction segment is anticipated to register high growth due to the rising elderly population, the rising prevalence of osteoporosis and osteoarthritis, and the rising incidence of road accidents and sports injuries. For instance, according to the United Nations report 2019, there were about 703 million people aged 65 years or over in the world in 2019. The number of older persons is anticipated to double to 1.5 billion in 2050. The rising elderly population is prone to the number of bone and joint disorders, which further fuels the market growth.
Additionally, companies are focusing on implementing strategies, such as mergers and acquisitions, product innovations, and recent developments, to gain a competitive advantage. For instance, in 2019, Smith & Nephew acquired Brainlab’s orthopedic joint reconstruction business. This acquisition is expected to boost the development and adoption of digital technologies to enhance efficiency and outcomes during surgeries, which may positively impact the market’s growth.
North America is Expected to Dominate the Market Over the Forecast Period
North America is expected to dominate the market due to the direct presence of key regional players, a strong distribution network, and a well-established healthcare infrastructure. Recent trends in the North American orthopedic devices market include the use of new polymer materials and the development of prosthetic devices as per the functional needs of patients.
Amid the pandemic, the procurement of equipment, especially capital equipment, has been on hold by a significant portion of hospitals performing amputation and orthopedic surgeries. All these factors are likely to affect the regional market growth. The pandemic has had ramifications on ways of working of various surgical procedures, including orthopedic surgeries. There were strict guidelines specific to each specialty that had to be implemented and followed for orthopedic surgeons to be able to continue to provide safe and effective care to their patients during the COVID-19 pandemic. For instance, in March 2020, in the United States, the National Association for the Advancement of Orthotics and Devices (NAAOP) issued an alert in which it was made clear that during the COVID-19 national emergency, state and local health authorities should consider orthotic and prosthetic practices as essential providers that must remain accessible to patients in need of orthotic and prosthetic care.
Furthermore, market players are focusing on developing novel orthopedic devices to satisfy the needs of users. For instance, in August 2021, The Orthopaedic Implant Company announced the FDA clearance and commercially launched the DRPx System, a wrist fracture plating technology. The system features an enhanced ergonomic design to meet the technique preferences of orthopedic surgeons with a cost-effective approach. Similarly, in September 2019, Active Implants’ NUsurface Meniscus Implant received the breakthrough designation from the United States Food and Drug Administration.
Such innovations to improve the efficiency of surgical procedures are expected to boost the market studied in the region.
Orthopedic Devices Market Competitor Analysis
The orthopedic devices market is highly fragmented. Market players focus on continuous product developments and offer orthopedic devices at competitive prices, especially in developing countries. Minimally invasive orthopedic devices, which do not require repeat procedures, are expected to boost the number of procedures in the developed and developing regions. Some of the companies currently dominating the market are B. Braun Melsungen AG, AGIS Network Inc., Medtronic PLC, Smith & Nephew PLC, Stryker Corporation, and Zimmer Biomet.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Large Joint Reconstruction Surgeries
4.2.2 Growing Burden of Orthopedic Disorders, Trauma, and Accidents Cases
4.2.3 Development of Bioabsorbable and Titanium Implants
4.3 Market Restraints
4.3.1 Stringent Regulatory Scenario
4.3.2 Poor Reimbursement Scenario and Lack of Skilled Surgeons
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 Application
5.1.1 Hip Orthopedic Devices
5.1.2 Joint Reconstruction
5.1.3 Knee Orthopedic Devices
5.1.4 Spine Orthopedic Devices
5.1.5 Trauma Fixation Devices
5.1.6 Dental Orthopedic Devices
5.1.7 Other Applications
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Aesculap Inc.
6.1.2 AGIS Network Inc.
6.1.3 Arthrex Inc.
6.1.4 ATEC Spine Inc.
6.1.5 B. Braun Melsungen AG
6.1.6 Boston Scientific Corporation
6.1.7 CTL Amedica
6.1.8 Globus Medical
6.1.9 Johnson & Johnson
6.1.10 Medtronic PLC
6.1.11 Ossur
6.1.12 Smith & Nephew PLC
6.1.13 Stryker Corporation
6.1.14 Zimmer Biomet
7 MARKET OPPORTUNITIES AND FUTURE TRENDS